Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature

• Elizabeth J. J. Berm ,

  Contributed equally to this work with: Elizabeth J. J. Berm, Margot de Looff

  * E-mail: e.j.j.berm@rug.nl

  Affiliation Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, Groningen, The Netherlands

  ⨯
• Margot de Looff ,

  Contributed equally to this work with: Elizabeth J. J. Berm, Margot de Looff

  Affiliation Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands

  ⨯
• Bob Wilffert,

  Affiliations Unit of Pharmacotherapy & Pharmaceutical Care, Department of Pharmacy, University of Groningen, Groningen, The Netherlands, Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

  ⨯
• Cornelis Boersma,

  Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands, GSK, Zeist, The Netherlands

  ⨯
• Lieven Annemans,

  Affiliation Faculty of Medicine & Health Science, Department of Public Health, Ghent University, Ghent, Belgium

  ⨯
• Stefan Vegter,

  Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands, GSK, Zeist, The Netherlands

  ⨯
• Job F. M. van Boven,

  Affiliation Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands

  ⨯
• Maarten J. Postma

  Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands, Institute of Science in Healthy Ageing & health care (SHARE), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

  ⨯